27 subscribers
Gå offline med appen Player FM !
Podcaster värda att lyssna på
SPONSRAD
Ibiayi Dagogo-Jack, MD / Jay M. Lee, MD - Reinforcing Precision Tactics in Genomically Altered Resectable NSCLC: Collaborative Workflows and Personalized Solutions for Integration of Adjuvant EGFR- and ALK-Targeted Therapies
Manage episode 447277545 series 1058605
For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/MZG865. CME/MOC/AAPA/IPCE credit will be available until November 9, 2025.
Reinforcing Precision Tactics in Genomically Altered Resectable NSCLC: Collaborative Workflows and Personalized Solutions for Integration of Adjuvant EGFR- and ALK-Targeted Therapies
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by independent educational grants from AstraZeneca and Genentech, a member of the Roche Group.
Disclosure information is available at the beginning of the video presentation.
228 episoder
Manage episode 447277545 series 1058605
For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/MZG865. CME/MOC/AAPA/IPCE credit will be available until November 9, 2025.
Reinforcing Precision Tactics in Genomically Altered Resectable NSCLC: Collaborative Workflows and Personalized Solutions for Integration of Adjuvant EGFR- and ALK-Targeted Therapies
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by independent educational grants from AstraZeneca and Genentech, a member of the Roche Group.
Disclosure information is available at the beginning of the video presentation.
228 episoder
All episodes
×1 Aaron B. Waxman, MD, PhD - Managing Pulmonary Arterial Hypertension in the Era of Novel and Emerging Treatment Options: It Takes a Village 49:12
1 Stephanie Christenson, MD, MAS, Cedric "Jamie" Rutland, MD, FCCP - Targeting a New Approach in COPD: Understanding the Potential Role of Biologic Therapy in Patients With Evidence of Type 2… 57:54
1 Javed Butler, MD, MPH, MBA / Muthiah Vaduganathan, MD, MPH - Experts vs AI: Exploring New Paradigms in Comprehensive Care for Cardio-Renal-Metabolic Diseases 1:09:59
1 Surya P. Bhatt, MD, MSPH - Breaking New Ground in the Treatment of COPD: Exploring the Potential Use of Targeted Biologic Therapy in Patients With Evidence of Type 2 Inflammation 20:53
1 Patrick M. Moriarty, MD, FACP, FACC, FNLA, FESC - Changing the Future for Families With HoFH: Long-Term Benefits of Early Diagnosis and Treatment for Homozygous Familial Hypercholesterolemia 59:00
1 Julie L. Rosenthal, MD, FACC, Ronald Witteles, MD - TTRansforming the TTReatment of ATTR: A Guide to the Pathophysiology, Diagnosis, and Emerging Treatment Strategies for ATTR Amyloidosis 1:05:02
1 Pamela J. McShane, MD - Experts vs AI Challenge: Diagnosing and Managing Nontuberculous Mycobacterial Lung Disease 56:10
1 Ibiayi Dagogo-Jack, MD / Jay M. Lee, MD - Reinforcing Precision Tactics in Genomically Altered Resectable NSCLC: Collaborative Workflows and Personalized Solutions for Integration of Adjuvant EGFR-… 44:25
1 Jessica Donington, MD, Jonathan D. Spicer, MD, PhD, FRCSC - Integrating Immunotherapy in Resectable NSCLC: How to Modify Treatment Trajectories and Reorganize Multidisciplinary Care Pathways 45:06
1 Dave Singh - Breathing New Life Into Treatment Approaches for COPD: The Latest Insights Into the Role of Type 2 Inflammation and Targeted Biologic Therapy 30:23
1 Suresh S. Ramalingam, MD, FACP, FASCO - Elevating Expectations, Broadening Impact: How to Leverage Immunotherapy and EGFR-Targeted Therapy to Improve Outcomes in Unresectable Stage III NSCLC 55:59
1 Taofeek K. Owonikoko, MD, PhD - Taking a BiTE Out of SCLC: Are You Ready for a New Wave of DLL3-Targeting T-Cell Engagers and Other Therapies? 30:52
1 Prof. Solange Peters, MD, PhD - Are We Closer to a Cure With Perioperative Immunotherapy in Resectable NSCLC? Latest Evidence, Current Conclusions, and Ongoing Questions in Clinical Care 21:36
1 Roy S. Herbst, MD, PhD - Elevating Care in Resectable Stage I-III NSCLC: Targeted Therapy and Immunotherapy at the Forefront of Multimodal Treatment Strategies 1:03:31
1 Natasha B. Leighl, MD, MMSc, FRCPC, FASCO - Navigating Rapid Changes in First- and Later-Line Treatment of EGFR-Mutated NSCLC: A Practical Framework for Optimal Biomarker Testing, Treatment… 59:03
1 Stephen V. Liu, MD - Updating the Lung Cancer Treatment Algorithms With Novel Antibody–Drug Conjugates: Are You Prepared for Change? State of the Science, Implications for Practice, and Future… 54:19
1 Marc S. Sabatine, MD, MPH - Emerging Options for Targeting PCSK9 in Hypercholesterolemia Management: Visualizing New Routes to Individualized Care 44:11
1 P. Barton Duell, MD - Lipid Management Beyond Statins: Early Screening, Prompt Intervention, and Timely Intensification With PCSK9-Targeted Therapies 48:07
1 Praveen Akuthota, MD - Recognizing the Burden of Patients Living With EGPA: An Exploration of Best Practices in Diagnosis and Treatment in the Context of a Multidisciplinary Approach 1:01:22
1 Ticiana Leal, MD - Achieving Optimal SCLC Care With Established and Innovative Therapies: Latest Evidence, Key Ongoing Trials, and Practical Considerations for Real-World Practice 1:27:09
1 Stephen V. Liu, MD - Decoding Biomarker Testing and Targeted Therapy in NSCLC: The Complete Guide for 2024 1:25:12
1 Geoffrey L. Chupp, MD / Autumn Burnette, MD, FACAAI - Leveraging the Power of Targeted Biologic Therapy in Severe Asthma: Do You Know How and For Whom? 35:56
1 Peter Voorhees, MD - Three Rs for Modern Myeloma Care: Delivering the Right Treatment for the Right Patient at the Right Time With Antibody and BCMA Platforms 1:53:24
1 Sandip Patel, MD - Illuminating the Path With Immunotherapy for Metastatic, Locally Advanced, and Early-Stage NSCLC: A Guide to Patient Assessment, Treatment Selection, and Multidisciplinary… 1:22:08
1 Kun "Kevin" Xiang, MD, PhD - Anticoagulation Therapy in NVAF: A Quality Improvement Initiative 30:17
1 William Anderson, MD - Improving Outcomes for Pediatric Patients With Uncontrolled Moderate-to-Severe Asthma Using a Collaborative Approach: Recognition, Referral, and Management in the Era of… 46:53
1 Brett Elicker, MD / David E. Griffith, MD, ATSF, ACCP, OFRSM - Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: Ensuring Prompt Diagnosis Through Accurate Interpretation… 54:24
1 Doreen J. Addrizzo-Harris, MD / Cedric "Jamie" Rutland, MD - Stories Behind the Science in Non-Cystic Fibrosis Bronchiectasis: Understanding Disease Burden, Diagnosing Early, and Looking Toward New… 59:42
1 Jessica Donington, MD - Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable NSCLC: A Case Exploration of New Standards and Emerging Approaches 48:09
1 Marianne Davies, DNP, ACNP, AOCNP, FAAN / Beth Sandy, MSN, CRNP, FAPO - Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices for Patient Education, irAE Management, and… 1:16:49
Välkommen till Player FM
Player FM scannar webben för högkvalitativa podcasts för dig att njuta av nu direkt. Den är den bästa podcast-appen och den fungerar med Android, Iphone och webben. Bli medlem för att synka prenumerationer mellan enheter.